1887

Abstract

Dihydrofolate reductase (DHFR) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (PurH) play key roles in maintaining folate pools in cells, and are targets of antimicrobial and anticancer drugs. While the activities of bacterial DHFR and PurH on their classical substrates (DHF and 10-CHO-THF, respectively) are known, their activities and kinetic properties of utilisation of 10-CHO-DHF are unknown. We have determined the kinetic properties (k cat/K m) of conversion of 10-CHO-DHF to 10-CHO-THF by DHFR, and to DHF by PurH. We show that DHFR utilises 10-CHO-DHF about one third as efficiently as it utilises DHF. The 10-CHO-DHF is also utilised (as a formyl group donor) by PurH albeit slightly less efficiently than 10-CHO-THF. The utilisation of 10-CHO-DHF by DHFR is ~50 fold more efficient than its utilisation by PurH. A folate deficient Escherichia coli (∆pabA) grows well when supplemented with adenine, glycine, thymine and methionine, the metabolites that arise from the one-carbon metabolic pathway. Notably, when the ∆pabA strain harboured a folate transporter, it grew in the presence of 10-CHO-DHF alone, suggesting that it (10-CHO-DHF) can enter one-carbon metabolic pathway to provide the required metabolites. Thus, our studies reveal that both DHFR and PurH could utilise 10-CHO-DHF for folate homeostasis in E. coli.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000671
2018-05-25
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/micro/164/7/982.html?itemId=/content/journal/micro/10.1099/mic.0.000671&mimeType=html&fmt=ahah

References

  1. Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr 1998; 157: S60– S66 [CrossRef] [PubMed]
    [Google Scholar]
  2. Rosenblatt D, Fowler B. Disorders of cobalamin and folate transport and metabolism. In Fernandes J, Saudubray J-M, Berghe G, Walter J. (editors) Inborn Metabolic Diseases Berlin, Heidelberg: Springer; 2006; pp. 341– 356 [Crossref]
    [Google Scholar]
  3. Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 2011; 34: 101– 109 [CrossRef] [PubMed]
    [Google Scholar]
  4. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94: 3290– 3295 [CrossRef] [PubMed]
    [Google Scholar]
  5. Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP et al. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 1999; 146: 35– 44 [CrossRef] [PubMed]
    [Google Scholar]
  6. Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 2004; 62: S3– S12 [CrossRef] [PubMed]
    [Google Scholar]
  7. Wagner C. Biochemical role of folate in cellular metabolism (Reprinted from folate and health disease, pgs 23–42, 1995). Clin Research & Reg Affairs 2001; 18: 161– 180 [Crossref]
    [Google Scholar]
  8. Poe M, Greenfield NJ, Hirshfield JM, Williams MN, Hoogsteen K. Dihydrofolate reductase. Purification and characterization of the enzyme from an amethopterin-resistant mutant of Escherichia coli. Biochemistry 1972; 11: 1023– 1030 [CrossRef] [PubMed]
    [Google Scholar]
  9. Huennekens FM. In search of dihydrofolate reductase. Protein Sci 1996; 5: 1201– 1208 [CrossRef] [PubMed]
    [Google Scholar]
  10. Schnell JR, Dyson HJ, Wright PE. Structure, dynamics, and catalytic function of dihydrofolate reductase. Annu Rev Biophys Biomol Struct 2004; 33: 119– 140 [CrossRef] [PubMed]
    [Google Scholar]
  11. Rabinowitz JC, Pricer WE. Formyltetrahydrofolate synthetase. I. Isolation and crystallization of the enzyme. J Biol Chem 1962; 237: 2898 [PubMed]
    [Google Scholar]
  12. Sah S, Aluri S, Rex K, Varshney U. One-carbon metabolic pathway rewiring in Escherichia coli reveals an evolutionary advantage of 10-formyltetrahydrofolate synthetase (Fhs) in survival under hypoxia. J Bacteriol 2015; 197: 717– 726 [CrossRef] [PubMed]
    [Google Scholar]
  13. D'Ari L, Rabinowitz JC. Purification, characterization, cloning, and amino acid sequence of the bifunctional enzyme 5,10-methylenetetrahydrofolate dehydrogenase/5,10-methenyltetrahydrofolate cyclohydrolase from Escherichia coli. J Biol Chem 1991; 266: 23953– 23958 [PubMed]
    [Google Scholar]
  14. Pino P, Aeby E, Foth BJ, Sheiner L, Soldati T et al. Mitochondrial translation in absence of local tRNA aminoacylation and methionyl tRNA Met formylation in Apicomplexa. Mol Microbiol 2010; 76: 706– 718 [CrossRef] [PubMed]
    [Google Scholar]
  15. Aiba A, Mizobuchi K. Nucleotide sequence analysis of genes purH and purD involved in the de novo purine nucleotide biosynthesis of Escherichia coli. J Biol Chem 1989; 264: 21239– 21246 [PubMed]
    [Google Scholar]
  16. Shim JH, Benkovic SJ. Evaluation of the kinetic mechanism of Escherichia coli glycinamide ribonucleotide transformylase. Biochemistry 1998; 37: 8776– 8782 [CrossRef] [PubMed]
    [Google Scholar]
  17. Wall M, Shim JH, Benkovic SJ. Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis. Biochemistry 2000; 39: 11303– 11311 [CrossRef] [PubMed]
    [Google Scholar]
  18. Schnell JR, Dyson HJ, Wright PE. Structure, dynamics, and catalytic function of dihydrofolate reductase. Annu Rev Biophys Biomol Struct 2004; 33: 119– 140 [CrossRef] [PubMed]
    [Google Scholar]
  19. Böck RA, Soulages JL, Barrow WW. Substrate and inhibitor specificity of Mycobacterium avium dihydrofolate reductase. FEBS J 2007; 274: 3286– 3298 [CrossRef] [PubMed]
    [Google Scholar]
  20. Guo J, Loveridge EJ, Luk LY, Allemann RK. Effect of dimerization on dihydrofolate reductase catalysis. Biochemistry 2013; 52: 3881– 3887 [CrossRef] [PubMed]
    [Google Scholar]
  21. Volpato JP, Fossati E, Pelletier JN. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase. J Mol Biol 2007; 373: 599– 611 [CrossRef] [PubMed]
    [Google Scholar]
  22. Baggott JE, Johanning GL. 10-Formyl-dihydrofolic acid is bioactive in human leukemia cells. J Nutr 1999; 129: 1315– 1318 [CrossRef] [PubMed]
    [Google Scholar]
  23. Zhang Y, Morar M, Ealick SE. Structural biology of the purine biosynthetic pathway. Cell Mol Life Sci 2008; 65: 3699– 3724 [CrossRef] [PubMed]
    [Google Scholar]
  24. Baggott JE, Vaughn WH, Hudson BB. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J 1986; 236: 193– 200 [CrossRef] [PubMed]
    [Google Scholar]
  25. Baggott JE, Tamura T. Evidence for the hypothesis that 10-formyldihydrofolate is the in vivo substrate for aminoimidazolecarboxamide ribotide transformylase. Exp Biol Med 2010; 235: 271– 277 [CrossRef] [PubMed]
    [Google Scholar]
  26. Baggott JE, Johanning GL, Branham KE, Prince CW, Morgan SL et al. Cofactor role for 10-formyldihydrofolic acid. Biochem J 1995; 308: 1031– 1036 [CrossRef] [PubMed]
    [Google Scholar]
  27. Stone SR, Morrison JF. Kinetic mechanism of the reaction catalyzed by dihydrofolate reductase from Escherichia coli. Biochemistry 1982; 21: 3757– 3765 [CrossRef] [PubMed]
    [Google Scholar]
  28. Sah S, Varshney U. Impact of mutating the key residues of a bifunctional 5,10-methylenetetrahydrofolate dehydrogenase-cyclohydrolase from Escherichia coli on its activities. Biochemistry 2015; 54: 3504– 3513 [CrossRef] [PubMed]
    [Google Scholar]
  29. Baggott JE, Krumdieck CL. Folylpoly-gamma-glutamates as cosubstrates of 10-formyltetrahydrofolate:5'-phosphoribosyl-5-amino-4-imidazolecarboxamide formyltransferase. Biochemistry 1979; 18: 1036– 1041 [CrossRef] [PubMed]
    [Google Scholar]
  30. Sambrook J, Russell D. Molecular Cloning, A Laboratory Manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001
    [Google Scholar]
  31. Smith GK, Mueller WT, Benkovic PA, Benkovic SJ. On the cofactor specificity of glycinamide ribonucleotide and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase from chicken liver. Biochemistry 1981; 20: 1241– 1245 [CrossRef] [PubMed]
    [Google Scholar]
  32. Díaz de La Garza R, Quinlivan EP, Klaus SM, Basset GJ, Gregory JF et al. Folate biofortification in tomatoes by engineering the pteridine branch of folate synthesis. Proc Natl Acad Sci USA 2004; 101: 13720– 13725 [CrossRef] [PubMed]
    [Google Scholar]
  33. Howell EE, Foster PG, Foster LM. Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement. J Bacteriol 1988; 170: 3040– 3045 [CrossRef] [PubMed]
    [Google Scholar]
  34. Baccanari D, Phillips A, Smith S, Sinski D, Burchall J. Purification and properties of Escherichia coli dihydrofolate reductase. Biochemistry 1975; 14: 5267– 5273 [CrossRef] [PubMed]
    [Google Scholar]
  35. Eudes A, Kunji ER, Noiriel A, Klaus SM, Vickers TJ et al. Identification of transport-critical residues in a folate transporter from the folate-biopterin transporter (FBT) family. J Biol Chem 2010; 285: 2867– 2875 [CrossRef] [PubMed]
    [Google Scholar]
  36. Stover P, Schirch V. 5-Formyltetrahydrofolate polyglutamates are slow tight binding inhibitors of serine hydroxymethyltransferase. JBiol Chem 1991; 266: 1543– 1550 [PubMed]
    [Google Scholar]
  37. Nixon MR, Saionz KW, Koo MS, Szymonifka MJ, Jung H et al. Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosis. Chem Biol 2014; 21: 819– 830 [CrossRef] [PubMed]
    [Google Scholar]
  38. Struck AW, Thompson ML, Wong LS, Micklefield J. S-adenosyl-methionine-dependent methyltransferases: highly versatile enzymes in biocatalysis, biosynthesis and other biotechnological applications. Chembiochem 2012; 13: 2642– 2655 [CrossRef] [PubMed]
    [Google Scholar]
  39. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2: 2006.0008 [CrossRef] [PubMed]
    [Google Scholar]
  40. Cherepanov PP, Wackernagel W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 1995; 158: 9– 14 [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000671
Loading
/content/journal/micro/10.1099/mic.0.000671
Loading

Data & Media loading...

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error